Lundgren et al. [8] demonstrated that in patients with EOC, increased tumoral CD20+ and CD138+ expression by IHC was associated with advanced tumor grade, and CD138 expression correlated significantly with reduced overall and cancer-specific survival. This evidence concerns the gene SDC1 and cancer.